로딩 중…
지수 로딩 중…
DHP Korea Co., Ltd.
131030· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,790+3.76%
2026-08-04
Financials
Valuation Metrics
DHP Korea Co., Ltd.'s Market Cap is ₩1022B. At end of 2025 it was ₩1214B. Ranked #1233 of 2,436 in KR market (top 51%), #658 of 1,649 on KOSDAQ (top 40%), #46 of 96 in Health Care Equipment & Services (top 48%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 102.17B KRW | KR#1,233/2,436 Sec#46/96 |
| Revenue | 91.62B KRW | KR#1,439/2,436 Sec#38/96 |
| Net Income | 12.70B KRW | KR#819/2,436 Sec#22/96 |
| Total Assets | 197.82B KRW | KR#1,289/2,436 Sec#35/96 |
| Net Assets | 176.05B KRW | KR#1,005/2,436 Sec#26/96 |
| Employees | 239 | KR#946/2,436 Sec#28/96 |
| Value | ||
| P/E | 8.05x | KR#567/2,436 Sec#13/96 |
| P/B | 0.58x | KR#947/2,436 Sec#14/96 |
| PEG | 0.07x | KR#327/2,436 Sec#10/96 |
| P/S | 1.12x | KR#1,474/2,436 Sec#33/96 |
| EV/EBITDA | 7.89x | KR#435/2,436 Sec#13/96 |
| FCF Yield | -27.69% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | 7.21% | KR#766/2,436 Sec#30/96 |
| ROA | 6.42% | KR#485/2,436 Sec#26/96 |
| Op. Margin | 11.85% | KR#399/2,436 Sec#26/96 |
| Revenue Growth | 23.83% | KR#574/2,436 Sec#26/96 |
| Earnings Growth | 113.88% | KR#386/2,436 Sec#17/96 |
| Financial Health | ||
| Debt Ratio | 112.37% | KR#495/2,436 Sec#21/96 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/96 |
| FCF | -28.29B KRW | KR#1,985/2,436 Sec#77/96 |
| Cash | 16.51B KRW | KR#1,365/2,436 Sec#42/96 |
| Current Ratio | 3.28x | KR#553/2,436 Sec#33/96 |
| Net Debt/EBITDA | -1.52x | KR#366/2,436 Sec#10/96 |
| Dividend | ||
| Div. Yield | 1.55% | KR#1,017/2,436 Sec#30/96 |
| Div. Growth | 0.62% | KR#670/2,436 Sec#23/96 |
| Performance | ||
| 1Y Return | -16.69% | KR#1,176/2,436 Sec#33/96 |
| 1M Return | -6.61% | KR#1,513/2,436 Sec#61/96 |
| From 52W High | -72.10% | KR#2,178/2,436 Sec#83/96 |
| 1Y MDD | -74.56% | KR#2,128/2,436 Sec#82/96 |
| Trading | ||
| Volume | 52,857 shares | KR#1,263/2,436 Sec#52/96 |
| Foreign Own. | 6.01% | KR#713/2,436 Sec#21/96 |
| Per Share | ||
| EPS | 758 KRW | KR#742/2,436 Sec#17/96 |
| BPS | 10,134 KRW | KR#934/2,436 Sec#19/96 |
Company Info
동사는 2010년 설립되어 2013년 디에이치피코리아와 합병하고, 2022년 옵투스제약으로 상호변경함. 눈 건조, 감염 등 안과 질환 예방 및 치료에 초점을 맞춘 점안액을 전문적으로 개발·제조하며, 안과 분야 전문 기업임. 2024년 신규공장 건축공사 착수로 연간 생산능력을 2026년까지 확대할 예정이며, AOA 교육 플랫폼 도입과 KAM 적용으로 제품 인지도 제고 및 거래처 관리 효율성을 개선하고 있음. 옵투스제약는 2010년에 설립되었으며 충청북도 청주시에 본사를 두고 있습니다.